IP Library Granted Patent US 7,067,630
Granted Patent B2
US 7,067,630 · App. 10/455,720 · Granted Jun 27, 2006

Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,067,630
App. No.
10/455,720
Granted
Jun 27, 2006
Kind
B2
Abstract

The present invention provides a TADG-12 protein and a DNA fragment encoding such protein. Also provided is a vector/host cell capable of expressing the DNA. The present invention further provides various methods of early detection of associated ovarian and other malignancies, and of interactive therapies for cancer treatment by utilizing the DNA and/or protein disclosed herein.

Claims (4)

1. An isolated and purified tumor associated differentially expressed gene-12 (TADG-12) protein coded for by DNA selected from the group consisting of:

(a) isolated DNA which encodes a TADG-12 protein, wherein said DNA comprises the polynucleotide sequence of SEQ ID No. 1 or 3 and;

(b) isolated DNA differing from the isolated DNAs of (a) above in codon sequence due to the degeneracy of the genetic code, and which encodes the TADG-12 protein of SEQ ID No. 2 or SEQ ID No. 4.

2. The isolated and purified TADG-12 protein of claim 1 , wherein said TADG-12 protein has the amino acid sequence selected from the group consisting of SEQ ID No. 2 and SEQ ID No. 4.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2017
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 044037/0496 →